How Does IGF-1 LR3 Compare to Tesamorelin?
IGF-1 LR3 Pack 1mg
This upstream-versus-downstream distinction is the core mechanistic difference between the two: Tesamorelin works by stimulating a natural, regulated physiological process (pituitary GH release, which the body's own feedback loops continue to govern), while IGF-1 LR3 is designed to bypass that entire regulatory cascade and act directly at the receptor for the axis's downstream signal.
Because Tesamorelin stimulates endogenous GH release rather than introducing a direct downstream signaling molecule, it is studied in a different research and regulatory context than IGF-1 LR3. Tesamorelin has an established clinical research history and regulatory approval history in specific therapeutic contexts, which is part of why REVIVE LAB UAE documents it as a catalog research peptide with lot-specific Certificates of Analysis, unlike IGF-1 LR3.
For researchers genuinely interested in growth-hormone-axis biology, this distinction is useful context: REVIVE LAB UAE's catalog covers the Tesamorelin/upstream side of this axis, not the IGF-1 LR3/downstream side. This page is comparative research information only and does not describe any dosing or administration for either compound.
AED 650 · Lot-specific COA on request · Cash on delivery or USDT (5% off) Order IGF-1 LR3 Pack UAE — Live Stock & Pricing